Briefs
Fiona Tyndall; Vesna Poljak; James Hall; Staff reporter
Novogen deeper in red
Biotechnology group Novogen made a loss of $20 million in 2006-07, up from $16 million in 2005-06, as research and development expenses increased. It will commit more cash to its clinical programs in 2007-08. Fiona Tyndall
Loading...
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Companies
Fetching latest articles